A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

PHASE3CompletedINTERVENTIONAL
Enrollment

607

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

April 30, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

MP29-02

azelastine HCl 548 mcg / fluticasone propionate 200 mcg nasal spray one spray per nostril twice a day

DRUG

azelastine Hcl

azelastine Hcl nasal spray one spray per nostril two times a day

DRUG

fluticasone propionate

fluticasone propionate 200 mcg nasal spray one spray per nostril two times a day

DRUG

placebo

placebo nasal spray one spray per nostril two times a day

Trial Locations (7)

76708

Allergy and Asthma Care, Waco

76712

Allergy and Asthma Center, Waco

78130

Central Texas Research, New Braunfels

78229

Southwest Allergy and Asthma Center, P.A., San Antonio

Sylvana Research Associates, San Antonio

78258

Allergy, Asthma Research Center, San Antonio

78731

Allergy and Asthma Associates, Austin

Sponsors
All Listed Sponsors
lead

Meda Pharmaceuticals

INDUSTRY